Position | Company | Period |
---|
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-06-27 | 2023-06-27 | B Purchase |
10,000
+28.6%
1.0610,587 USD |
10,000 +28.6% | 1.06 | 10,587 USD | ||
2023-03-27 | 2023-03-23 | B Purchase |
35,002
+inf%
0.8630,207 USD |
35,002 +inf% | 0.86 | 30,207 USD | ||
2023-03-27 | 2023-03-23 | B Purchase |
35,000
+18.3%
0.8630,160 USD |
35,000 +18.3% | 0.86 | 30,160 USD | ||
2022-08-25 | 2022-08-25 |
Aeglea Bio Therapeutics Inc
(AGLE)
|
B Purchase |
90,000
+inf%
0.5650,472 USD |
90,000 +inf% | 0.56 | 50,472 USD | |
2022-06-09 | 2022-06-08 | B Purchase |
27,000
+16.6%
1.8549,888 USD |
27,000 +16.6% | 1.85 | 49,888 USD | ||
2020-11-10 | 2020-11-10 | B Purchase |
3,846
+18.7%
26.08100,304 USD |
3,846 +18.7% | 26.08 | 100,304 USD | ||
2020-02-12 | 2020-02-10 |
PTC Therapeutics Inc
(PTCT)
|
PS Planned sale |
625
-8.5%
53.9233,700 USD |
625 -8.5% | 53.92 | 33,700 USD | |
2020-01-27 | 2020-01-23 |
PTC Therapeutics Inc
(PTCT)
|
S Sale |
154
-2.9%
53.258,200 USD |
154 -2.9% | 53.25 | 8,200 USD | |
2020-01-08 | 2020-01-06 |
PTC Therapeutics Inc
(PTCT)
|
PS Planned sale |
86
-1.6%
48.174,142 USD |
86 -1.6% | 48.17 | 4,142 USD | |
2019-06-04 | 2019-06-03 |
PTC Therapeutics Inc
(PTCT)
|
PS Planned sale |
5,490
-8.6%
40.38221,686 USD |
5,490 -8.6% | 40.38 | 221,686 USD | |
2019-01-09 | 2019-01-07 |
PTC Therapeutics Inc
(PTCT)
|
PS Planned sale |
83
-2.9%
34.752,884 USD |
83 -2.9% | 34.75 | 2,884 USD |